Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-430116
Filing Date
2013-11-06
Accepted
2013-11-06 16:19:16
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d613130d10q.htm 10-Q 587909
2 EX-10.1 d613130dex101.htm EX-10.1 4022
3 EX-10.2 d613130dex102.htm EX-10.2 83011
4 EX-31.1 d613130dex311.htm EX-31.1 6192
5 EX-31.2 d613130dex312.htm EX-31.2 6216
6 EX-32.1 d613130dex321.htm EX-32.1 4123
  Complete submission text file 0001193125-13-430116.txt   4249057

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT alxa-20130930.xml EX-101.INS 511233
8 XBRL TAXONOMY EXTENSION SCHEMA alxa-20130930.xsd EX-101.SCH 42522
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxa-20130930_cal.xml EX-101.CAL 53833
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxa-20130930_def.xml EX-101.DEF 140027
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxa-20130930_lab.xml EX-101.LAB 353200
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxa-20130930_pre.xml EX-101.PRE 246878
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Filer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51820 | Film No.: 131196709
SIC: 2834 Pharmaceutical Preparations